A case of secretory carcinoma of the submandibular gland with unusual immunohistochemical staining

被引:8
作者
Karabachev, Alexander [1 ]
Aulet, Ricardo [2 ]
Sajisevi, Mirabelle [2 ]
Ciolino, Allison [3 ]
机构
[1] Univ Vermont, Robert Larner Coll Med, 89 Beaumont Ave, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Surg, Med Ctr, Div Otolaryngol, Burlington, VT 05405 USA
[3] Univ Vermont, Dept Pathol & Lab Med, Med Ctr, Burlington, VT USA
关键词
acinar cell carcinoma; carcinoma; head and neck neoplasms; salivary gland; submandibular gland; ACINIC CELL CARCINOMAS; SALIVARY-GLAND; DIAGNOSIS; UPDATE; MASC;
D O I
10.1002/ccr3.2927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mammaglobin negative secretory carcinoma may be overlooked. It is important to assess the possibility of diagnosis when histology is suggestive and immunohistochemical staining for S-100 is positive even when staining for mammaglobin is negative.
引用
收藏
页码:1530 / 1533
页数:4
相关论文
共 17 条
[1]  
Barnes L, 2005, WHO CLASSIFICATION T, P216
[2]   Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma [J].
Bishop, Justin A. ;
Yonescu, Raluca ;
Batista, Denise ;
Begum, Shahnaz ;
Eisele, David W. ;
Westra, William H. .
HUMAN PATHOLOGY, 2013, 44 (10) :1982-1988
[3]  
Bishop JA, 2013, AM J SURG PATHOL, V37, P1053, DOI 10.1097/PAS.0b013e3182841554
[4]   Unmasking MASC: Bringing to Light the Unique Morphologic, Immunohistochemical and Genetic Features of the Newly Recognized Mammary Analogue Secretory Carcinoma of Salivary Glands [J].
Bishop J.A. .
Head and Neck Pathology, 2013, 7 (1) :35-39
[5]   Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands [J].
Chiosea, Simion I. ;
Griffith, Christopher ;
Assaad, Adel ;
Seethala, Raja R. .
HISTOPATHOLOGY, 2012, 61 (03) :387-394
[6]   Mammary analogue secretory carcinoma (MASC) of the salivary gland: A new tumor entity [J].
Damjanov, Ivan ;
Skenderi, Faruk ;
Vranic, Semir .
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 16 (03) :237-238
[7]   Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children [J].
Drilon, A. ;
Laetsch, T. W. ;
Kummar, S. ;
DuBois, S. G. ;
Lassen, U. N. ;
Demetri, G. D. ;
Nathenson, M. ;
Doebele, R. C. ;
Farago, A. F. ;
Pappo, A. S. ;
Turpin, B. ;
Dowlati, A. ;
Brose, M. S. ;
Mascarenhas, L. ;
Federman, N. ;
Berlin, J. ;
El-Deiry, W. S. ;
Baik, C. ;
Deeken, J. ;
Boni, V. ;
Nagasubramanian, R. ;
Taylor, M. ;
Rudzinski, E. R. ;
Meric-Bernstam, F. ;
Sohal, D. P. S. ;
Ma, P. C. ;
Raez, L. E. ;
Hechtman, J. F. ;
Benayed, R. ;
Ladanyi, M. ;
Tuch, B. B. ;
Ebata, K. ;
Cruickshank, S. ;
Ku, N. C. ;
Cox, M. C. ;
Hawkins, D. S. ;
Hong, D. S. ;
Hyman, D. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) :731-739
[8]   STARTRK-2: A global phase 2, open-label, basket study of entrectinib in patients with locally advanced or metastatic solid tumors harboring TRK, ROS1, or ALK gene fusions [J].
Drilon, Alexander ;
Sankhala, Kamalesh Kumar ;
Liu, Stephen V. ;
Cho, Byoung Chul ;
Blakely, Collin ;
Chee, Cheng E. ;
Fakih, Marwan ;
Polikoff, Jonathan ;
Hornby, Zachary ;
Schechet, Lisa ;
Luo, David ;
Maneval, Edna Chow ;
Multani, Pratik S. ;
Doebele, Robert C. .
CANCER RESEARCH, 2017, 77
[9]  
Lei Y, 2012, HEAD NECK PATHOL, V6, P166, DOI 10.1007/s12105-011-0312-9
[10]   Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement [J].
Majewska, Hanna ;
Skalova, Alena ;
Stodulski, Dominik ;
Klimkova, Adela ;
Steiner, Petr ;
Stankiewicz, Czesaw ;
Biernat, Wojciech .
VIRCHOWS ARCHIV, 2015, 466 (03) :245-254